Abstract 4370542: Strength Amidst Strain: Determinants of Resilience in Pediatric and Young Adult Fontan Circulatory Failure
Abstract
Background: Resilience describes an individual’s ability to leverage internal strengths, external support, and acquired skills to maintain wellbeing amidst stressors. Individuals with Fontan-palliated congenital heart disease (CHD) often face physical and psychological stressors, yet some report resilience amidst these circumstances. While resilience is linked to important physical and psychological outcomes in other chronic illnesses, it is underexplored in pediatric and young adult CHD. Research Question: This prospective study aimed to 1) characterize self-reported resilience in a multi-center sample of children and young adults with Fontan circulatory failure (FCF) and 2) identify demographic, physical, and psychological factors correlated with resilience. Methods: Pediatric and young adult patients with Fontan circulation referred for heart failure evaluation at 20 North American pediatric heart centers were eligible. Participants completed the Connor-Davidson Resilience Scale (CD-RISC©). CD-RISC© scores range from 0-40. In adults, scores < 29 represent the lowest quartile. In pediatric cancer and adult CHD, mean scores of 29 have been reported. Participants also completed a measure of disease burden/benefit and NIH PROMIS surveys assessing life satisfaction, purpose in life, depression, and anxiety. Medical data was obtained from chart reviews, and frailty was assessed using the Lurz-Wilde pediatric frailty criteria. Results: The study included 131 participants (60% male, 78% White, median age 16.1 years) with a mean CD-RISC score of 27.2 (SD=7.2; Figure 1). Lower resilience was associated with younger age (p<0.0001), female sex (p=0.01), and hypoplastic left heart syndrome (HLHS; p=0.049). Lower resilience (p=0.001), higher anxiety (p=0.01), and high self-reported disease burden (p=0.02) correlated with frailty. Few objective FCF comorbidities were associated with resilience. In univariate analysis, protein losing enteropathy (PLE; p=0.04) and clinical cyanosis (p=0.053) were associated with lower resilience. In multivariate analysis including age, sex, HLHS diagnosis, and PLE, only younger age and female sex remained independently associated with lower resilience. Conclusion: Although young people with FCF report high resilience, many indicate opportunities for intervention. The study underlines resilience as a modifiable, critical target for intervention in complex CHD, highlighted by its strong link with frailty over less modifiable comorbidities.
Article Details
Authors (26)
Melissa Cousino
Adriana Batazzi
University of Michigan, Ann Arbor, Michigan, United States
SunKyung Yu
Garrett Reichle
UNIVERSITY OF MICHIGAN, Ann Arbor, Michigan, United States
Shahnawaz Amdani
Maria Bano
UT Southwestern, Dallas, Texas, United States
Elizabeth Blume
Boston Children's Hospital, Boston, Massachusetts, United States
David Bearl
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Jennifer Conway
Brian Feingold
UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
Michelle Ploutz
University of Utah, Salt Lake City, Utah, United States
Shriprasad Deshpande
Children's National Health System, Washington, District of Columbia, United States
Matthew O'Connor
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Humera Ahmed
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Sharon Chen
University of Utah, Salt Lake City, Utah, United States
Lydia Wright
Pediatric Cardiology Nationwide Children’s Hospital, Columbus, OH (L.W.).
Steven Kindel
Childrens Hospital of Wisconsin, Milwaukee, Wisconsin, United States
Chad Mao
Emory, Atlanta, Georgia, United States
Angela Lorts
Kathleen Simpson
Colorado Children's, Denver, Colorado, United States
Aecha Ybarra
Washington University in St. Louis, St. Louis, Missouri, United States
Anna Joong
Lurie Children's Hospital, Chicago, Illinois, United States
Chiu-Yu Chen
Stanford University, Palo Alto, California, United States
Marc Richmond
COLUMBIA UNIVERSITY MSCHONY, New York, New York, United States
David Rosenthal
MD Anderson Cancer Center, Houston, Texas, United States
Kurt Schumacher